These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients. Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B Transplant Proc; 1997 Nov; 29(7A):16S-17S. PubMed ID: 9366920 [No Abstract] [Full Text] [Related]
24. Antibody response to horse gamma-globulin in recipients of renal allografts: relationship with transplant crises and transplant survival. Vincent C; Revillard JP Transplantation; 1977 Aug; 24(2):141-7. PubMed ID: 70872 [TBL] [Abstract][Full Text] [Related]
25. Lymphocyte subsets during and after rabbit anti-thymocyte globulin induction in pediatric renal transplantation: sustained T cell depletion. Bell L; Girardin C; Sharma A; Goodyer P; Mazer B Transplant Proc; 1997 Nov; 29(7A):6S-9S. PubMed ID: 9366917 [No Abstract] [Full Text] [Related]
26. Anti-thymocyte globulin therapy induced a spurious increase of fibrinogen degradation products in hypoplastic myelodysplastic syndrome. Yahata Y; Isobe Y; Sasaki M; Oshimi K; Sugimoto K Eur J Haematol; 2009 May; 82(5):404. PubMed ID: 19191866 [No Abstract] [Full Text] [Related]
27. Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients. Marfo K; Akalin E; Wang C; Lu A Am J Health Syst Pharm; 2011 Dec; 68(23):2276-82. PubMed ID: 22095818 [TBL] [Abstract][Full Text] [Related]
28. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D; N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of heterophilic antibodies in serum samples from horses in an equine hospital, and elimination of interference using chicken IgY. Dong B; Bergman D; Holst BS Acta Vet Scand; 2021 Mar; 63(1):10. PubMed ID: 33712042 [TBL] [Abstract][Full Text] [Related]
30. Experience with antilymphocyte globulin in 144 renal transplant recipients. Lundgren G; Collste L; Groth CG; Krzymansky M; Magnusson G; Quadracci L; Ringdén O; Svehag SE Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849 [TBL] [Abstract][Full Text] [Related]
31. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient. Kutzler HL; Ye X; Rochon C; Martin ST Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892 [TBL] [Abstract][Full Text] [Related]
32. False increase in serum C-reactive protein caused by monoclonal IgM-lambda: a case report. Yu A; Pira U Clin Chem Lab Med; 2001 Oct; 39(10):983-7. PubMed ID: 11758616 [TBL] [Abstract][Full Text] [Related]
33. Cross-reactivity between swine leukocyte antigen and human anti-HLA-specific antibodies in sensitized patients awaiting renal transplantation. Díaz Varela I; Sánchez Mozo P; Centeno Cortés A; Alonso Blanco C; Valdés Cañedo F J Am Soc Nephrol; 2003 Oct; 14(10):2677-83. PubMed ID: 14514748 [TBL] [Abstract][Full Text] [Related]
34. An extended lymphocytotoxicity test for patients treated with lymphocytotoxic antibodies. Moldenhauer A; Kohlhaus R; Salama A Vox Sang; 2000; 78(4):250-3. PubMed ID: 10895099 [TBL] [Abstract][Full Text] [Related]
35. Rapid serologic diagnosis of serum sickness from antithymocyte globulin therapy using enzyme immunoassay. Tatum AH; Bollinger RR; Sanfilippo F Transplantation; 1984 Dec; 38(6):582-6. PubMed ID: 6334386 [TBL] [Abstract][Full Text] [Related]
36. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies. Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887 [TBL] [Abstract][Full Text] [Related]